Skip to content
Study details
Enrolling now

Ketamine-Assisted Group Therapy Trial

Juliana Zambrano, MD, MPH
NCT IDNCT06597695ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1/2

Target enrollment

10

Study length

about 11 months

Ages

18–64

Locations

1 site in MA

About this study

Researchers are testing a new treatment called ketamine-assisted psychotherapy for people who speak Spanish and have depression. The goal is to see if it's safe, feasible, and might help with their depression. The trial will last about 343 days.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Take Ketamine-assisted psychotherapy
PhasePhase 1/Phase 2
DrugKetamine-assisted psychotherapy

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low15%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug classes

anesthetic (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)

Endpoints

Secondary: Investigate the preliminary efficacy of the group-based ketamine intervention on psychiatric symptoms, wellbeing, and health behaviors among Spanish-speaking participants with depression.

Body systems

Psychiatry / Mental Health